EMAIL THIS PAGE TO A FRIEND

General pharmacology

A new beta-adrenoceptor blocking agent derived from dehydrozingerone.


PMID 7958725

Abstract

1. Dehydrozingeronolol (DZPN; 0.1, 0.5, 1.0 mg/kg, i.v.) produced a dose-dependent bradycardia response and a sustained pressor action in urethane-anesthetized normotensive rats. DZPN inhibited the tachycardia effects by (-)isoproterenol, but had no blocking effect on the arterial pressor responses induced by phenylephrine. 2. In in vitro study, DZPN antagonized (-)isoproterenol-induced positive chronotropic effects in guinea-pig isolated right atria and relaxation responses in rat isolated uterus horns. 3. DZPN causes mild direct cardiac depression at high concentrations without intrinsic sympathomimetic activity (ISA). 4. The order of potency of beta-adrenoceptor antagonists in competing for the [3H]dihydroalprenolol binding sites was (-)propranolol > DZPN > or = atenolol.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

07551
Vanillylidenacetone, ≥98.5%
C11H12O3